Discover
ATXS
Astria Therapeutics, Inc.
12.58
2 x 8.95
2 x 16.00
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
12.58 +0.00 (0.00%)
| Ytd | -3.90% | |
| 1y | 66.62% |
12.45
day range
12.59
6.58
52 week range
16.90
| Open | Prev Close | 12.58 | Low | 12.45 | High | 12.59 | Mkt Cap | 538.38M | |
| Vol | 0.00 | Avg Vol | 323.01K | EPS | -2.18 | P/E | N/A | Forward P/E | -5.39 |
| Beta | 0.71 | Short Ratio | 12.52 | Inst. Own | 101.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 10.63 | 200-d Avg | 10.85 | 1yr Est | 26.43 |
| Income Statement | |||
| Total Revenue | 706.00K | ||
| Revenues (USD) | 706.00K | ||
| Gross Profit | 706.00K | ||
| Operating Expenses | 34.81M | ||
| Research and Development Expense | 24.15M | ||
| Selling, General and Administrative Expense | 10.66M | ||
| Operating Income | -34.10M | ||
| Net Income | -31.64M | ||
| Net Income Common Stock | -31.64M | ||
| Net Income Common Stock (USD) | -31.64M | ||
| Consolidated Income | -31.64M | ||
| Earnings per Basic Share | -0.55 | ||
| Earnings per Basic Share (USD) | -0.55 | ||
| Earnings per Diluted Share | -0.55 | ||
| Earning Before Interest & Taxes (EBIT) | -31.64M | ||
| Earning Before Interest & Taxes (USD) | -31.64M | ||
| Weighted Average Shares | 58.01M | ||
| Weighted Average Shares Diluted | 58.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 96.28M | ||
| Cash and Equivalents (USD) | 96.28M | ||
| Investments | 131.44M | ||
| Investments Current | 131.44M | ||
| Trade and Non-Trade Receivables | 17.24M | ||
| Current Assets | 253.55M | ||
| Property, Plant & Equipment Net | 4.25M | ||
| Total Assets | 271.87M | ||
| Debt Current | 1.40M | ||
| Total Debt | 4.46M | ||
| Current Liabilities | 23.52M | ||
| Debt Non-Current | 3.06M | ||
| Total Liabilities | 38.61M | ||
| Accumulated Retained Earnings (Deficit) | -773.20M | ||
| Accumulated Other Comprehensive Income | 56.00K | ||
| Shareholders Equity | 233.25M | ||
| Shareholders Equity (USD) | 233.25M | ||
| Assets Non-Current | 18.32M | ||
| Total Debt (USD) | 4.46M | ||
| Deferred Revenue | 16.54M | ||
| Liabilities Non-Current | 15.10M | ||
| Trade and Non-Trade Payables | 1.14M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 19.96M | ||
| Issuance (Purchase) of Equity Shares | 3.00K | ||
| Net Cash Flow from Investing | 52.25M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 52.25M | ||
| Net Cash Flow from Operations | -32.29M | ||
| Share Based Compensation | 4.31M | ||